查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405903

生物樣本庫市場規模、佔有率、趨勢分析報告：按產品、生物檢體類型、生物樣本庫類型、服務、應用、地區、細分市場預測，2024-2030

Biobank Market Size, Share & Trends Analysis Report By Product (LIMS, Biobanking Equipment), By Biospecimen Type (Organs, Stem Cells), By Biobank Type (Real, Virtual), By Service, By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 185 Pages | 商品交期: 2-10個工作天內

價格

生物樣本庫市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球生物樣本庫市場規模預計將達到1,369.1億美元，預測期內複合年成長率為8.8%。

隨著NGS等新技術的引入以及對基因組醫學的日益關注，生物樣本庫不斷發展。多種類型的生物樣本可用於藥物研發、診斷等多個領域，這正在加速生物樣本庫的多元化並推動市場發展。生物樣本的品質對疾病檢測以及臨床前和臨床研究有重大影響。監管機構透過制定有效樣本管理指南，在促進生物樣本庫服務的採用方面發揮重要作用。

例如，美國疾病管制與預防中心 (CDC) 發布了指南，以最大程度地減少處理 COVID-19 樣本期間對人類造成的風險。它已成為其他生物樣本庫的典範。此外，與 COVID-19 相關的研究和臨床試驗數量的增加預計將在不久的將來顯著增加對高品質生物樣本的需求，從而導致市場成長。此外，生物檢體資料庫促進了基於人群的隊列研究，以估計實際的血清盛行率。 Health Catalyst, Inc. 透過其 Touchstone 平台提供與 COVID-19 見解相關的國家資料。這些因素預計將有助於該行業的收益。

BioResource 由 RareCan 於 2021 年 10 月創立，RareCan 是一家總部位於赫克瑟姆的醫療保健新興企業公司，致力於改善型態癌症的研究。 BioResource 保存癌症患者手術後採集的樣本，並讓世界各地的研究人員可以使用這些樣本來治療、預防和識別疾病。 2021 年 12 月，紐卡斯爾大學推出了新的人體血液樣本和人體組織捐贈採集方案。英國生物銀行宣布，資料庫中增加了測量一系列循環代謝組學生物標記的研究的新資料。 Nightingale Health 是一家專門從事血液生物標記技術的芬蘭公司，對 12 萬名參與者進行了這項研究。

此外，美國的 COVID-19 病例數量很高，而且研究和開發項目的增加導致了新生物樣本庫的建立，這推動了北美的收益。隨著亞洲國家藥品和臨床研究領域的不斷擴大，預計亞太地區將成為市場成長最快的地區。主要參與者正在努力透過與全球經銷商的合作夥伴關係、與其他參與者的併購以及與研究界的策略聯盟來擴大其全球影響力。

生物樣本庫市場報告亮點

  • 由於生物銀行庫數量不斷增加，加上設備高成本，生物樣本庫設備部門在 2023 年佔據最大的收益佔有率。
  • 由於這些服務的高普及以及在精準醫學和特異性疾病研究的發展中對生物樣本儲存的需求不斷成長，生物樣本庫和儲存庫服務生物銀行在 2023 年佔據了最大的收益佔有率。
  • 人體組織是臨床研究中保存最完好的樣本，導致這種樣本類型在市場上佔據主導地位。
  • 由於生物醫學研究對罕見疾病資料的需求以及對 3D 生物標本的需求不斷成長，預計虛擬生物庫產業將在預測期內實現最快的複合年成長率。
  • 2023年，由於癌症治療的細胞療法日益普及，治療藥物應用領域佔據了最大的收益佔有率。
  • 一些製藥/生物技術公司已經建立了私人銀行來支持臨床試驗和細胞療法的開發，從而導致該領域的企業收益成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章生物樣本庫市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 生物樣本庫市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章生物樣本庫市場：產品評估與趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 按產品分類的全球生物樣本庫市場展望
  • 2018年至2030年市場規模、預測與趨勢分析如下
    • 生物樣本庫設備
    • 生物銀行耗材
    • 實驗室資訊管理系統

第5章生物樣本庫市場：服務評估與趨勢分析

  • 2023年及2030年服務市場佔有率
  • 細分儀表板
  • 按服務分類的全球生物樣本庫市場展望
  • 2018年至2030年市場規模、預測與趨勢分析如下
    • 生物銀行和儲存庫
    • 實驗室加工
    • 資格/檢驗
    • 低溫運輸物流
    • 其他服務

第6章生物樣本庫市場：生物檢體類型的估計和趨勢分析

  • 2023 年和 2030 年生物檢體類型市場佔有率
  • 細分儀表板
  • 按生物檢體類型分類的全球生物樣本庫市場展望
  • 2018年至2030年市場規模、預測與趨勢分析如下
    • 人體組織
    • 人體器官
    • 幹細胞
    • 其他生物標本

第7章生物樣本庫市場：生物樣本庫類型的估計與趨勢分析

  • 生物樣本庫類型市場佔有率，2023 年和 2030 年
  • 細分儀表板
  • 按生物樣本庫類型分類的全球生物樣本庫市場展望
  • 2018年至2030年市場規模、預測與趨勢分析如下
    • 物理/現實生物樣本庫
    • 虛擬生物樣本庫

第8章生物樣本庫市場：應用估算與趨勢分析

  • 2023年及2030年應用市場佔有率
  • 細分儀表板
  • 按應用分類的全球生物樣本庫市場展望
  • 2018年至2030年市場規模、預測與趨勢分析如下
    • 治療
    • 藥物研發與臨床研究
    • 臨床診斷
    • 其他用途

第9章生物樣本庫市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
  • 供應商形勢
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023 年主要企業股票分析
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Qiagen
    • Hamilton Company
    • Tecan Trading AG
    • Danaher Corporation
    • Becton, Dickinson, and Company（BD）
    • Biocision, LLC.
    • Taylor-Wharton
    • Charles River Laboratories
    • Lonza
    • Stemcell Technologies
    • Biovault Family
    • Promocell Gmbh
    • Precision Cellular Storage Ltd.（Virgin Health Bank）
Product Code: GVR-2-68038-564-9

Biobanks Market Growth & Trends:

The global biobanks market size is expected to reach USD 136.91 billion by 2030, registering a CAGR of 8.8% during the forecast period, according to a new report by Grand View Research, Inc. Biobanks continue to evolve with the introduction of new technologies, such as NGS, and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market. The quality of biospecimens can significantly influence disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples.

For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples. This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.

The 'BioResource' was created in October 2021 by RareCan, a Hexham-based healthcare start-up dedicated to improving studies into the uncommon forms of cancer. BioResource will retain samples taken after surgery from cancer patients and make them accessible to researchers across the globe who can use them to cure, prevent, and identify the disease. In December 2021, Newcastle University introduced a new collection of human blood samples and donated human tissue, which could transform efforts to cure rare cancers. The U.K. Biobank has announced that fresh data from a study measuring the range of circulatory metabolomics biomarkers has been added to its database. Nightingale Health, a Finnish business specializing in blood biomarker technologies, conducted the study with 120000 participants.

North America dominated the market with its wide network of centers for biosample storage in the U.S. Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving revenue in North America. In Asia Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across Asian countries. The key players are engaged in expanding their global reach by partnering with global distributors, mergers, and acquisitions of other players, and entering a strategic alliance with research communities.

Biobanks Market Report Highlights:

  • The biobanking equipment segment accounted for the maximum revenue share in 2023 owing to the high cost of instruments coupled with an increase in the number of biorepositories
  • The biobanking and repository services segment accounted for the largest revenue share in 2023 due to the higher penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research
  • Human tissues are the most stored sample for clinical research, resulting in the dominance of this sample type in the market
  • The virtual biobanks segment is anticipated to witness the fastest CAGR during the forecast period owing to the growing demand for 3D biospecimens coupled with the need for rare disease data for biomedical research
  • The therapeutics application segment accounted for the largest revenue share in 2023 owing to the growing popularity of cell therapies for cancer treatment
  • Several pharma/biotech companies have established their private banks to support clinical trials and the development of cell therapies, resulting in revenue growth in this segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Service
    • 1.2.3. Biospecimen Type
    • 1.2.4. Biobanks Type
    • 1.2.5. Application
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Service outlook
    • 2.2.3. Biospecimen type outlook
    • 2.2.4. Biobanks type outlook
    • 2.2.5. Application outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Biobanks Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Continuous increase in COVID-19 cases along with capacity expansion
      • 3.2.1.2. Increased focus on precision medicine and genetic testing
      • 3.2.1.3. Changes in biobanking operations
      • 3.2.1.4. Increase in the number of clinical trials globally
      • 3.2.1.5. Growing industry and research collaborations
      • 3.2.1.6. Technology advancement and automation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Disruptions in supply chain management due to COVID-19
      • 3.2.2.2. Challenges in sharing biobanking data & limited access to biospecimens
      • 3.2.2.3. Sustainability challenges for biobanks
      • 3.2.2.4. Other challenges in biobanking specimens for research
  • 3.3. Biobanks Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Biobanks Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Biobanks Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Biobank Equipment
      • 4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Temperature Control Systems
      • 4.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2.2. Freezers & Refrigerators
      • 4.4.1.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2.3. Cryogenic Storage Systems
      • 4.4.1.2.4. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2.5. Thawing Equipment
      • 4.4.1.2.6. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Incubators & Centrifuges
      • 4.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.4. Alarms & Monitoring Systems
      • 4.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.5. Accessories & Other Equipment
      • 4.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Biobanking Consumables
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Laboratory Information Management Systems
      • 4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Biobanks Market: Service Estimates & Trend Analysis

  • 5.1. Service Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Biobanks Market by Service Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Biobanking & repository
      • 5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Lab processing
      • 5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Qualification/ Validation
      • 5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Cold Chain Logistics
      • 5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.5. Other Services
      • 5.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Biobanks Market: Biospecimen Type Estimates & Trend Analysis

  • 6.1. Biospecimen Type Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Biobanks Market by Biospecimen Type Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Human Tissues
      • 6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Human Organs
      • 6.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. Stem Cells
      • 6.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.3.2. Adult Stem Cells
      • 6.4.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.3.3. Embryonic Stem Cells
      • 6.4.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.3.4. IPS Cells
      • 6.4.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.3.5. Other Stem Cells
      • 6.4.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.4. Other biospecimens
      • 6.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Biobanks Market: Biobanks Type Estimates & Trend Analysis

  • 7.1. Biobanks Type Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Biobanks Market by Biobanks Type Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Physical/Real biobanks
      • 7.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 7.4.1.2. Tissue Biobanks
      • 7.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 7.4.1.3. Population based biobanks
      • 7.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 7.4.1.4. Genetic (DNA/RNA)
      • 7.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 7.4.1.5. Disease based biobanks
      • 7.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Virtual biobanks
      • 7.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Biobanks Market: Application Estimates & Trend Analysis

  • 8.1. Application Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Global Biobanks Market by Application Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.4.1. Therapeutics
      • 8.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. Drug discovery & clinical research
      • 8.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. Clinical Diagnostics
      • 8.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Other Applications
      • 8.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Biobanks Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.6. Thailand
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.2. Mexico
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.3. Argentina
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework/reimbursement structure
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company market share analysis, 2023
    • 10.3.4. Thermo Fisher Scientific Inc.
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Merck KGaA
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Qiagen
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Hamilton Company
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Tecan Trading AG
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Danaher Corporation
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Becton, Dickinson, and Company (BD)
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Biocision, LLC.
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Taylor-Wharton
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Charles River Laboratories
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Lonza
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Product benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. Stemcell Technologies
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Product benchmarking
      • 10.3.15.4. Strategic initiatives
    • 10.3.16. Biovault Family
      • 10.3.16.1. Company overview
      • 10.3.16.2. Financial performance
      • 10.3.16.3. Product benchmarking
      • 10.3.16.4. Strategic initiatives
    • 10.3.17. Promocell Gmbh
      • 10.3.17.1. Company overview
      • 10.3.17.2. Financial performance
      • 10.3.17.3. Product benchmarking
      • 10.3.17.4. Strategic initiatives
    • 10.3.18. Precision Cellular Storage Ltd. (Virgin Health Bank)
      • 10.3.18.1. Company overview
      • 10.3.18.2. Financial performance
      • 10.3.18.3. Product benchmarking
      • 10.3.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 5 North America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 6 North America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 7 North America biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 10 U.S. biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 11 U.S. biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 12 U.S. biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 13 Canada biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 15 Canada biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 16 Canada biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 17 Canada biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 19 Europe biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 20 Europe biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 21 Europe biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 22 Europe biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 23 Europe biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 24 Germany biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 25 Germany biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 26 Germany biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 27 Germany biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 28 Germany biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 29 UK biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 31 UK biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 32 UK biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 33 UK biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 34 France biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 35 France biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 36 France biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 37 France biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 38 France biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 39 Italy biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 40 Italy biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 41 Italy biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 42 Italy biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 43 Italy biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 45 Spain biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 46 Spain biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 47 Spain biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 48 Spain biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 51 Denmark biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 52 Denmark biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 53 Denmark biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 54 Sweden biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 55 Sweden biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 56 Sweden biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 57 Sweden biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 58 Sweden biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 59 Norway biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 60 Norway biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 61 Norway biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 62 Norway biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 63 Norway biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 70 China biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 71 China biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 72 China biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 73 China biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 74 China biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 75 Japan biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 76 Japan biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 77 Japan biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 78 Japan biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 79 Japan biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 80 India biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 81 India biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 82 India biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 83 India biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 84 India biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 86 South Korea biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 87 South Korea biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 88 South Korea biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 89 South Korea biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 90 Australia biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 91 Australia biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 92 Australia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 93 Australia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 94 Australia biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 95 Thailand biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 96 Thailand biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 97 Thailand biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 98 Thailand biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 99 Thailand biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 100 Latin America biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 101 Latin America biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 102 Latin America biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 103 Latin America biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 104 Latin America biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 105 Brazil biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 106 Brazil biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 107 Brazil biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 108 Brazil biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 109 Brazil biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 110 Mexico biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 111 Mexico biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 112 Mexico biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 113 Mexico biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 114 Mexico biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 115 Argentina biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 116 Argentina biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 117 Argentina biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 118 Argentina biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 119 Argentina biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 120 MEA biobanks market, by region, 2018 - 2030 (USD Million)
  • Table 121 MEA biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 122 MEA biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 123 MEA biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 124 MEA biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 125 MEA biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 126 South Africa biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 127 South Africa biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 128 South Africa biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 129 South Africa biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 130 South Africa biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 131 Saudi Arabia biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 136 UAE biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 137 UAE biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 138 UAE biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 139 UAE biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 140 UAE biobanks market, by application, 2018 - 2030 (USD Million)
  • Table 141 Kuwait biobanks market, by product, 2018 - 2030 (USD Million)
  • Table 142 Kuwait biobanks market, by service, 2018 - 2030 (USD Million)
  • Table 143 Kuwait biobanks market, by biospecimen type, 2018 - 2030 (USD Million)
  • Table 144 Kuwait biobanks market, by biobanks type, 2018 - 2030 (USD Million)
  • Table 145 Kuwait biobanks market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Biobanks market: market outlook
  • Fig. 14 Biobanks competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Biobanks market driver impact
  • Fig. 20 Biobanks market restraint impact
  • Fig. 21 Biobanks market strategic initiatives analysis
  • Fig. 22 Biobanks market: Product movement analysis
  • Fig. 23 Biobanks market: Product outlook and key takeaways
  • Fig. 24 Biobanking equipment market estimates and forecast, 2018 - 2030
  • Fig. 25 Temperature control systems estimates and forecast, 2018 - 2030
  • Fig. 26 Freezers & refrigerators market estimates and forecast, 2018 - 2030
  • Fig. 27 Cryogenic storage systems market estimates and forecast, 2018 - 2030
  • Fig. 28 Thawing equipment market estimates and forecast, 2018 - 2030
  • Fig. 29 Incubators & centrifuges market estimates and forecast, 2018 - 2030
  • Fig. 30 Alarms & monitoring systems market estimates and forecast, 2018 - 2030
  • Fig. 31 Accessories & other equipment market estimates and forecast, 2018 - 2030
  • Fig. 32 Biobanking consumables market estimates and forecast, 2018 - 2030
  • Fig. 33 Laboratory information management systems market estimates and forecast, 2018 - 2030
  • Fig. 34 Biobanks Market: Service movement Analysis
  • Fig. 35 Biobanks market: Service outlook and key takeaways
  • Fig. 36 Biobanking & repository market estimates and forecasts, 2018 - 2030
  • Fig. 37 Lab processing market estimates and forecasts,2018 - 2030
  • Fig. 38 Qualification/ Validation market estimates and forecasts,2018 - 2030
  • Fig. 39 Cold chain logistics market estimates and forecasts, 2018 - 2030
  • Fig. 40 Other services market estimates and forecasts,2018 - 2030
  • Fig. 41 Biobanks market: Biospecimen type movement analysis
  • Fig. 42 Biobanks market: Biospecimen type outlook and key takeaways
  • Fig. 43 Human tissues market estimates and forecasts, 2018 - 2030
  • Fig. 44 Human organs market estimates and forecasts,2018 - 2030
  • Fig. 45 Stem cells market estimates and forecasts, 2018 - 2030
  • Fig. 46 Adult stem cells market estimates and forecasts,2018 - 2030
  • Fig. 47 Embryonic stem cells market estimates and forecasts, 2018 - 2030
  • Fig. 48 IPS cells market estimates and forecasts, 2018 - 2030
  • Fig. 49 Other stem cells market estimates and forecasts, 2018 - 2030
  • Fig. 50 Other biospecimen market estimates and forecasts, 2018 - 2030
  • Fig. 51 Biobanks market: Biobanks type movement analysis
  • Fig. 52 Biobanks market: Biobanks type outlook and key takeaways
  • Fig. 53 Physical/Real biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 54 Tissue biobanks market estimates and forecasts,2018 - 2030
  • Fig. 55 Population based biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 56 Genetic (DNA/RNA) market estimates and forecasts,2018 - 2030
  • Fig. 57 Disease based biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 58 Virtual biobanks market estimates and forecasts, 2018 - 2030
  • Fig. 59 Biobanks market: Application movement analysis
  • Fig. 60 Biobanks market: Application outlook and key takeaways
  • Fig. 61 Therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 62 Drug discovery & clinical research market estimates and forecasts,2018 - 2030
  • Fig. 63 Clinical diagnostics market estimates and forecasts, 2018 - 2030
  • Fig. 64 Other applications market estimates and forecasts,2018 - 2030
  • Fig. 65 Global biobanks market: Regional movement analysis
  • Fig. 66 Global biobanks market: Regional outlook and key takeaways
  • Fig. 67 Global biobanks market share and leading players
  • Fig. 68 North America market share and leading players
  • Fig. 69 Europe market share and leading players
  • Fig. 70 Asia Pacific market share and leading players
  • Fig. 71 Latin America market share and leading players
  • Fig. 72 Middle East & Africa market share and leading players
  • Fig. 73 North America: SWOT
  • Fig. 74 Europe SWOT
  • Fig. 75 Asia Pacific SWOT
  • Fig. 76 Latin America SWOT
  • Fig. 77 MEA SWOT
  • Fig. 78 North America, by country
  • Fig. 79 North America
  • Fig. 80 North America market estimates and forecasts, 2018 - 2030
  • Fig. 81 U.S.
  • Fig. 82 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 83 Canada
  • Fig. 84 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 85 Europe
  • Fig. 86 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 87 UK
  • Fig. 88 UK market estimates and forecasts, 2018 - 2030
  • Fig. 89 Germany
  • Fig. 90 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 91 France
  • Fig. 92 France market estimates and forecasts, 2018 - 2030
  • Fig. 93 Italy
  • Fig. 94 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 95 Spain
  • Fig. 96 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 97 Denmark
  • Fig. 98 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 99 Sweden
  • Fig. 100 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 101 Norway
  • Fig. 102 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 103 Asia Pacific
  • Fig. 104 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 105 China
  • Fig. 106 China market estimates and forecasts, 2018 - 2030
  • Fig. 107 Japan
  • Fig. 108 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 109 India
  • Fig. 110 India market estimates and forecasts, 2018 - 2030
  • Fig. 111 Thailand
  • Fig. 112 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 113 South Korea
  • Fig. 114 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 115 Australia
  • Fig. 116 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 117 Latin America
  • Fig. 118 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 119 Brazil
  • Fig. 120 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 121 Mexico
  • Fig. 122 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 123 Argentina
  • Fig. 124 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 125 Middle East and Africa
  • Fig. 126 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 127 South Africa
  • Fig. 128 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 129 Saudi Arabia
  • Fig. 130 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 131 UAE
  • Fig. 132 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 133 Kuwait
  • Fig. 134 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 135 Market share of key market players- Biobanks market